These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 18218062

  • 1. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
    Kowalik A, Rimpau W, Adam H, Kühn F, van Oene J, Schreiner A, Bogdanow M, Schauble B, TOPMAT-EPY-405 investigators.
    Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
    [Abstract] [Full Text] [Related]

  • 2. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A, Stollhoff K, Ossig W, Unkelbach S, Lüer W, Bogdanow M, Schauble B, TOPMAT-EPY-403 investigators.
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [Abstract] [Full Text] [Related]

  • 3. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY, Fan TT, Zhu P, He RQ, Bao YX, Zheng RY, Xu HQ.
    PLoS One; 2015 May; 10(7):e0131566. PubMed ID: 26147937
    [Abstract] [Full Text] [Related]

  • 4. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
    Majkowski J, Neto W, Wapenaar R, Van Oene J.
    Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
    [Abstract] [Full Text] [Related]

  • 5. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR.
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [Abstract] [Full Text] [Related]

  • 6. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C, Witt JA.
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [Abstract] [Full Text] [Related]

  • 7. [Oxcarbazepine in the treatment of epilepsy].
    Freidel M, Krause E, Kuhn K, Peper R, Vogel H.
    Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
    [Abstract] [Full Text] [Related]

  • 8. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
    Albani F, Baruzzi A, "PRIMO" Study Group.
    Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
    [Abstract] [Full Text] [Related]

  • 9. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F, Lang SY, Wang XQ, Shi XB, Ma YF, Zhang X, Chen YN, Zhang JT.
    Chin Med J (Engl); 2015 Nov 20; 128(22):3015-22. PubMed ID: 26608980
    [Abstract] [Full Text] [Related]

  • 10. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
    Sunwoo JS, Park BS, Ahn SJ, Hwang S, Park CY, Jun JS, Kim DW, Lee ST, Jung KH, Park KI, Chu K, Jung KY, Lee SK.
    Clin Neuropharmacol; 2017 Nov 20; 40(2):56-62. PubMed ID: 28118167
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S, Boppana P, Toguri J, DeSantis A.
    Epilepsia; 2006 Mar 20; 47(3):510-5. PubMed ID: 16529614
    [Abstract] [Full Text] [Related]

  • 12. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW, Lee SY, Shon YM, Kim JH.
    Epilepsia; 2013 Oct 20; 54(10):e146-9. PubMed ID: 23980720
    [Abstract] [Full Text] [Related]

  • 13. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
    Sachdeo RC, Gates JR, Bazil CW, Barkley GL, Tatum W, D'Souza J, McCague K.
    Epilepsy Behav; 2006 Nov 20; 9(3):457-63. PubMed ID: 16934534
    [Abstract] [Full Text] [Related]

  • 14. Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
    Maschio M, Albani F, Jandolo B, Zarabla A, Contin M, Dinapoli L, Fabi A, Pace A, Baruzzi A.
    J Neurooncol; 2008 Nov 20; 90(2):217-21. PubMed ID: 18612799
    [Abstract] [Full Text] [Related]

  • 15. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K, Lengler U, Rettig K, Schreiner A, Schauble B, TOP-GER-3 investigators.
    Seizure; 2007 Oct 20; 16(7):593-600. PubMed ID: 17543544
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
    Dogan EA, Usta BE, Bilgen R, Senol Y, Aktekin B.
    Epilepsy Behav; 2008 Jul 20; 13(1):156-61. PubMed ID: 18331816
    [Abstract] [Full Text] [Related]

  • 17. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Jul 20; 110(5 Suppl 1):39-44. PubMed ID: 20559266
    [Abstract] [Full Text] [Related]

  • 18. Topiramate in refractory epilepsy: a prospective observational study.
    Stephen LJ, Sills GJ, Brodie MJ.
    Epilepsia; 2000 Aug 20; 41(8):977-80. PubMed ID: 10961624
    [Abstract] [Full Text] [Related]

  • 19. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D, Elger CE.
    Epilepsy Behav; 2004 Oct 20; 5(5):627-35. PubMed ID: 15380112
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E, Faught E, Krumholz A, Naritoku D, Privitera M, Schwarzman L, Mao L, Wiegand F, Hulihan J, CAPSS-272 Study Group.
    Epilepsia; 2010 Oct 20; 51(10):1970-7. PubMed ID: 20633037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.